254 related articles for article (PubMed ID: 27788718)
1. [Changes in serum β2-microglobulin, retinol-binding protein, and cystatin C and their value in identifying early renal dysfunction in patients with chronic hepatitis B undergoing tenofovir or entecavir monotherapy: a comparative analysis].
He J; Ning HB; Zeng YL; Li W; Li K; Shang J
Zhonghua Gan Zang Bing Za Zhi; 2016 Sep; 24(9):643-646. PubMed ID: 27788718
[No Abstract] [Full Text] [Related]
2. Value of Cystatin C-Based e-GFR Measurements to Predict Long-Term Tenofovir Nephrotoxicity in Patients With Hepatitis B.
Koksal AR; Alkim H; Boga S; Iyisoy MS; Sen I; Tekin Neijmann S; Alkim C
Am J Ther; 2019; 26(1):e25-e31. PubMed ID: 27753647
[TBL] [Abstract][Full Text] [Related]
3. Changes in Renal Function in Patients With Chronic HBV Infection Treated With Tenofovir Disoproxil Fumarate vs Entecavir.
Trinh S; Le AK; Chang ET; Hoang J; Jeong D; Chung M; Lee MH; Wang U; Henry L; Cheung R; Nguyen MH
Clin Gastroenterol Hepatol; 2019 Apr; 17(5):948-956.e1. PubMed ID: 30130625
[TBL] [Abstract][Full Text] [Related]
4. Tenofovir monotherapy for hepatitis B after 1 year does not produce renal dysfunction, but is associated with hyperparathyroidism not related to vitamin D.
Patricio JA; Lopes PF; Medeiros T; Mendes GF; Silva AA; Esberard EB; Lugon JR; Almeida JR
Eur J Gastroenterol Hepatol; 2016 Jan; 28(1):64-9. PubMed ID: 26545084
[TBL] [Abstract][Full Text] [Related]
5. Early kidney injury during long-term adefovir dipivoxil therapy for chronic hepatitis B.
Jia HY; Ding F; Chen JY; Lian JS; Zhang YM; Zeng LY; Xiang DR; Yu L; Hu JH; Yu GD; Cai H; Lu YF; Zheng L; Li LJ; Yang YD
World J Gastroenterol; 2015 Mar; 21(12):3657-62. PubMed ID: 25834334
[TBL] [Abstract][Full Text] [Related]
6. Altered Underlying Renal Tubular Function in Patients With Chronic Hepatitis B Receiving Nucleos(t)ide Analogs in a Real-World Setting: The MENTE Study.
Rodríguez-Nóvoa S; García-Samaniego J; Prieto M; Calleja JL; Pascasio JM; Delgado Blanco M; Crespo J; Buti M; Bonet Vidal ML; Arenas Ruiz Tapiador J; Fernández-Rodríguez C; Solá R; Fraga E; González Diéguez L; Núñez O; Praga M; Del Pino-Montes J; Romero-Gómez M; Morillas R; Diago M; Castro Á;
J Clin Gastroenterol; 2016 Oct; 50(9):779-89. PubMed ID: 27332746
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the efficacy and safety of entecavir and tenofovir in nucleos(t)ide analogue-naive chronic hepatitis B patients with high viraemia: a retrospective cohort study.
Wu IT; Hu TH; Hung CH; Lu SN; Wang JH; Lee CM; Chen CH
Clin Microbiol Infect; 2017 Jul; 23(7):464-469. PubMed ID: 28189857
[TBL] [Abstract][Full Text] [Related]
8. Preprocedure and Postprocedure Predictive Values of Serum β2-Microglobulin for Contrast-Induced Nephropathy in Patients Undergoing Coronary Computed Tomography Angiography: A Comparison With Creatinine-Based Parameters and Cystatin C.
Li S; Zheng Z; Tang X; Peng L; Luo Y; Dong R; Zhao Y; Liu J
J Comput Assist Tomogr; 2015; 39(6):969-74. PubMed ID: 26248154
[TBL] [Abstract][Full Text] [Related]
9. Effects of entecavir, tenofovir and telbivudine treatment on renal functions in chronic hepatitis B patients.
Kara AV; Yıldırım Y; Ozcicek F; Aldemir MN; Arslan Y; Bayan K; Çelen MK
Acta Gastroenterol Belg; 2019; 82(2):273-277. PubMed ID: 31314188
[TBL] [Abstract][Full Text] [Related]
10. Comparison of renal safety of tenofovir and entecavir in patients with chronic hepatitis B: Systematic review with meta-analysis.
Lee HY; Oh H; Park CH; Yeo YH; Nguyen MH; Jun DW
World J Gastroenterol; 2019 Jun; 25(23):2961-2972. PubMed ID: 31249453
[TBL] [Abstract][Full Text] [Related]
11. Comparison of renal safety and efficacy of telbivudine, entecavir and tenofovir treatment in chronic hepatitis B patients: real world experience.
Tsai MC; Chen CH; Tseng PL; Hung CH; Chiu KW; Wang JH; Lu SN; Lee CM; Chang KC; Yen YH; Lin MT; Chou YP; Hu TH
Clin Microbiol Infect; 2016 Jan; 22(1):95.e1-95.e7. PubMed ID: 26055419
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the effectiveness and renal safety of tenofovir versus entecavir in patients with chronic hepatitis B.
López Centeno B; Collado Borrell R; Pérez Encinas M; Gutiérrez García ML; Sanmartin Fenollera P
Farm Hosp; 2016 Jun; 40(4):279-86. PubMed ID: 27571496
[TBL] [Abstract][Full Text] [Related]
13. Effect of nucleoside and nucleotide analogues on renal function in patients with chronic hepatitis B virus monoinfection.
Mallet V; Schwarzinger M; Vallet-Pichard A; Fontaine H; Corouge M; Sogni P; Pol S
Clin Gastroenterol Hepatol; 2015 Jun; 13(6):1181-8.e1. PubMed ID: 25460550
[TBL] [Abstract][Full Text] [Related]
14. Similar risk of renal events among patients treated with tenofovir or entecavir for chronic hepatitis B.
Gish RG; Clark MD; Kane SD; Shaw RE; Mangahas MF; Baqai S
Clin Gastroenterol Hepatol; 2012 Aug; 10(8):941-6; quiz e68. PubMed ID: 22507876
[TBL] [Abstract][Full Text] [Related]
15. Tenofovir versus tenofovir plus entecavir for chronic hepatitis B with lamivudine resistance and entecavir resistance.
Lee S; Ahn SH; Jung KS; Kim DY; Kim BK; Kim SU; Baatarkhuu O; Ku HJ; Han K; Park JY
J Viral Hepat; 2017 Feb; 24(2):141-147. PubMed ID: 27766731
[TBL] [Abstract][Full Text] [Related]
16. [Influence of monotherapy with telbivudine or entecavir on renal function in patients with chronic hepatitis B].
Li W; Zhang D
Zhonghua Gan Zang Bing Za Zhi; 2015 Jun; 23(6):407-11. PubMed ID: 26236924
[TBL] [Abstract][Full Text] [Related]
17. A 24-week, parallel-group, open-label, randomized clinical trial comparing the early antiviral efficacy of telbivudine and entecavir in the treatment of hepatitis B e antigen-positive chronic hepatitis B virus infection in adult Chinese patients.
Zheng MH; Shi KQ; Dai ZJ; Ye C; Chen YP
Clin Ther; 2010 Apr; 32(4):649-58. PubMed ID: 20435234
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness and safety of switching to entecavir hepatitis B patients developing kidney dysfunction during tenofovir.
Viganò M; Loglio A; Labanca S; Zaltron S; Castelli F; Andreone P; Messina V; Ganga R; Coppola N; Marrone A; Russello M; Marzano A; Tucci A; Taliani G; Fasano M; Fagiuoli S; Villa E; Bronte F; Santantonio T; Brancaccio G; Occhipinti V; Facchetti F; Grossi G; Rumi M; Lampertico P
Liver Int; 2019 Mar; 39(3):484-493. PubMed ID: 30525275
[TBL] [Abstract][Full Text] [Related]
19. Cystatin C, Beta2 Microglobulin, N-Acetyl-beta-D-glucosaminidase, Retinol-Binding Protein, and Endothelin 1 Levels in the Evaluation of Sickle Cell Disease Nephropathy.
Unal S; Kotan C; Delibas A; Oztas Y
Pediatr Hematol Oncol; 2015 May; 32(4):250-7. PubMed ID: 23987825
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the Efficacy of Tenofovir Versus Tenofovir plus Entecavir in the Treatment of Chronic Hepatitis B in Patients With Poor Efficacy of Entecavir: A Systematic Review and Meta-analysis.
Chen J; Zhao SS; Liu XX; Huang ZB; Huang Y
Clin Ther; 2017 Sep; 39(9):1870-1880. PubMed ID: 28797777
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
